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Mexican American Admixture Mapping Panel, by
Tian et al. (p. 1014)
Latino Admixture Map, by Price et al. (p. 1024)
Genomewide Admixture Mapping Panel for
Hispanic/Latino Populations, by Mao et al. (p.
1171)
The Hispanic/Latino American population is the largest
minority population in the United States. The people are
descendents of European, Native American, and African
populations, so are considered to be admixed. Admixture
mapping can be used for such a group to identify genetic
variants that are associated with diseases that are more
prevalent in one founding population than they are in
another. If a founding population has a high genetic dis-
ease risk, then it is assumed that the disease alleles in
subsequent admixed populations will be associated with
genomic segments from the at-risk founding population.
To effectively distinguish which regions of an admixed
genome come from which founding population, it is nec-
essary to have a genomewide set of markers that are found
at different frequencies in each population. Tian et al.,
Price et al., and Mao et al. have approached this matter
in somewhat different fashions, to assemble such a panel
of informative markers. These panels will serve as critical
tools in the endeavor to search for new disease genes by
use of admixture mapping in Hispanic/Latino American
populations.
SLC26A4 Transcription Control in PS-EVA, by Yang
et al. (p. 1055)
Pendred syndrome (PS) and a type of nonsyndromic hear-
ing loss with enlarged vestibular aqueduct (EVA) are both
caused by mutations in SLC26A4. Although family evi-
dence supports recessive inheritance of PS and EVA, a large
proportion of affected individuals carry only a singleknown
mutant allele. A possible alternative mechanism for the
development of these diseases was suggested by work with
mice deﬁcient for the transcription factor Foxi1. These
mice do not express Slc26a4, and they demonstrate hear-
ing loss with EVA, so it was predicted that activation by
FOXI1 would also be required for proper SLC26A4 ex-
pression in humans. Yang et al. examined the noncoding
regions of SLC26A4 in a large number of PS/EVA–affected
families, in many of which only one or no known mu-
tation had been identiﬁed. In nine families, the authors
found a single nucleotide change in the promoter region
that was expected to disrupt a consensus binding site for
FOXI1. The authors then demonstrated that thismutation
signiﬁcantly reduced the ability of FOXI1 to bind to the
promoter and to activate SLC26A4 expression. The inter-
action between the two genes was further elucidated by
the identiﬁcation of patients in the group who had mu-
tations in FOXI1. These mutant FOXI1 proteins were also
unable to effectively activate SCL26A4.
Detection of Multifactor Interactions, by Lou et al.
(p. 1125)
There is increasing evidence that it is important to con-
sider gene-gene and gene-environment interactions when
searching for the causative factors of complex diseases.
Because detection of such interactions by use of methods
designed to study a single factor at a time can fail and/
or be computationally unfeasible, multifactor approaches
have been developed. One such algorithm, themultifactor
dimensionality reduction method (MDR), is more com-
putationally tractable than are other approaches, but it
has been restricted by limitations, including its inability
to handle covariates and be applied to continuous traits.
Lou et al. addressed these issues in their development of
a generalized form of MDR (GMDR), which increases the
ﬂexibility and application of the method. Their simula-
tions demonstrate the increased accuracy achieved with
the consideration of covariates. The GMDR was also ap-
plied to genotyping data from a study searching for an
association between four candidate genes and nicotine de-
pendence. Although the independentmain effects of SNPs
in two of the genes were nonsigniﬁcant, a signiﬁcant in-
teraction between the two genes was identiﬁed.
Causes of Skewed X Inactivation, by Muers et al.
(p. 1138)
In general, X-chromosome inactivation (XCI) is expected
to occur at random in unaffected females, so that thenum-
ber of cells expressing the maternal X chromosome is
roughly equal to the number expressing the paternal X
chromosome. In situations of X-linked disease, the inac-
tivation is often signiﬁcantly skewed in carriers, such that
expression of the X chromosome without the disease mu-
tation is preferred. Female carriers of one such disease,
ATR-X syndrome, have skewing in several tissue types, and
Muers et al. were interested to ﬁnd out the mechanism
behind the altered X-chromosome expression. Using a
mouse model of Atrx deﬁciency, the authors set out to
determine whether the skewing was the result of a fun-
damental dysfunction of the XCI process, a selection step
early in embryogenesis that affected all subsequent cells,
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or tissue-speciﬁc selection that occurred later in develop-
ment. By following the ratio of XCI in developing em-
bryos, the authors observed that, by late gestation, skew-
ing increased in a cell-speciﬁc manner. Additional analysis
of the skewing in the hematopoietic system revealed that,
although cell selection occurred early in the establishment
of the stem cell population, an absence of skewing if the
expression of Atrx was abolished postnatally suggested that
Atrx was not necessary for adult hematopoiesis.
DYT1 Intragenic Modiﬁcation of Susceptibility, by
Risch et al. (p. 1188)
A recurrent GAG deletion mutation in DYT1 is the most
common cause of primary torsion dystonia (PTD), a dis-
order involving a wide range of focal or generalized dys-
tonia. Although the mutation is necessary for the devel-
opment of PTD, the penetrance of the mutation has been
estimated to be ∼30%. This has led to the hypothesis that
modifying factors must contribute to the eventual pheno-
type expression. Risch et al. decided to look at how other
sequence variants within DYT1 might affect the function-
al consequences of the GAG deletion. The GAG mutation
is thought to cause disease by producing a dysfunctional
DYT1 gene product that causes inclusions of endoplasmic
reticula in vitro. A second variant in DYT1 has recently
been identiﬁed that also has this effect in cell culture, but,
interestingly, the presence of the two variants together
results in the formation of fewer inclusions. With this ob-
servation in mind, the authors measured the frequency
of DYT1 variants in GAG carriers with PTD and in those
carriers without PTD. They discovered that the previously
described SNP, in line with its ability to modify the inclu-
sion effect of the GAG mutation in vitro, was more fre-
quent in carriers without a PTD phenotype. Although this
variant was rare and could not explain the reduced pen-
etrance of the GAG deletion in its entirety, the measure-
ment of its effect is expected to signiﬁcantly add to the
genetics-counseling information available for those who
carry the SNP.
This Month on the Cover
In 1908, Godfrey HaroldHardy (Science 28:49–50) andWil-
helm Weinberg (Jahreshefte des Vereins fu¨r vaterla¨ndische
Naturkunde in Wu¨rttemberg 64:368–382) each indepen-
dently determined an expression to represent the stability
of allele and genotype frequencies within an ideal popula-
tion. Hardy-Weinberg equilibrium predicts that allele fre-
quencies will remain constant over time. This equilibrium
applies to loci in populations that are not affected by in-
breeding, migration, small population size, assortativemat-
ing, natural selection, or mutation. The Hardy-Weinberg
equation, , denotes the frequency of al-2 2p  2pq q p 1
lele A with the variable “p” and denotes the frequency of
allele a with the variable “q.” For a population meeting
the criteria for Hardy-Weinberg equilibrium, the geno-
typic frequency of AA should equal , the frequency of2p
Aa should equal , and the frequency of aa should equal2pq
. On the cover, the frequencies of the three genotypes2q
of a biallelic locus in Hardy-Weinberg equilibrium are
graphed versus the frequency of allele a. Special thanks to
Andrew Kirby for assistance with the image.
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